Related Experiment Video
Updated: Feb 1, 2026
09:03
Forward Genetic Approaches in Chlamydia trachomatis
Published on: October 23, 2013
13.3K
[¿Azitromicina como tratamiento contra Chlamydia trachomatis?]
José Luis Maldonado-Calderón1, Francisco Carlos López-Márquez1, Pablo Ruiz-Flores1
1Universidad Autónoma de Coahuila, Centro de Investigación Biomédica, Coahuila, México.
Gaceta Medica De Mexico
|December 12, 2018
Summary
Azithromycin and doxycycline are effective for urogenital chlamydiasis. Doxycycline shows an advantage in treating rectal chlamydiasis, though azithromycin remains a preferred option due to single-dose convenience.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Background:
- Urogenital chlamydiasis treatment efficacy has long been established for azithromycin and doxycycline.
- Autoinoculation is a suspected factor in persistent chlamydial infections in women, potentially linked to azithromycin's tissue pharmacokinetics.
- Antimicrobial resistance is not a significant issue, as no in vivo treatment-resistant strains have been identified.
Purpose of the Study:
- To compare the effectiveness of azithromycin and doxycycline in treating urogenital and rectal chlamydiasis.
- To evaluate the role of autoinoculation and pharmacokinetics in treatment outcomes.
- To assess the impact of new diagnostic methods and tests of cure on treatment selection.
Main Methods:
- Utilized new diagnostic methods and tests of cure to evaluate treatment effectiveness.
- Compared treatment outcomes for urogenital and rectal chlamydiasis.
- Considered pharmacokinetic properties and potential for autoinoculation in treatment persistence.
Main Results:
- Both azithromycin and doxycycline demonstrated effectiveness in treating urogenital chlamydiasis.
- Doxycycline showed a demonstrable advantage over azithromycin in the treatment of rectal chlamydiasis.
- No significant role of antimicrobial resistance was observed in treatment failures.
Conclusions:
- Azithromycin and doxycycline remain effective choices for urogenital chlamydiasis.
- Doxycycline is a more effective option for rectal chlamydiasis.
- Azithromycin's single-dose administration favors patient adherence, maintaining its status as a first-choice treatment.
Related Concept Videos
01:29Bacterial Phylum Chlamydiae
505
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
505
01:27Open Angle Glaucoma: Treatment
996
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
996
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
01:24Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
01:22Alzheimer's Disease: Treatment
949
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
949
01:26Anticholinesterase Agents: Poisoning and Treatment
1.6K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.6K